TROY, Mich.-- Convenience is important to everyone, but to a patient with a serious illness or chronic disease, having a convenience that reduces their doctor and hospital visits can make life much easier.

Delphi Medical Systems, a subsidiary of Delphi Corp., introduces VitalPoint™ Home, a new vital signs monitoring system that gives patients the flexibility to have their health practitioner check on them remotely – no matter where he or she is in the world. The doctor, nurse or other caregiver simply logs on to a secure website through their PC or PDA – checking patient information quickly and easily.

VitalPoint™ Home reads a patient's blood pressure, glucose level, pulse rate, respiratory rate, pulse oximetry, temperature and weight. Once vital signs are recorded, they are automatically sent to a Delphi Medical website via a regular phone line.

Medical professionals then get the information by logging onto a secure website and viewing the information, as needed, from their PC, laptop or PDA. Also, alerts or "limits" can be set so that the doctor or nurse can receive SMS messages, emails, or voicemails in case attention needs to be given to a particular patient. Furthermore, specific reminders can be sent to the patient, via the small table top monitor, which weighs only three pounds.

"While VitalPoint™ Home can't replace all face-to-face visits between the health practitioner and the patient every time, it can limit visits and keep patients in constant contact with their caregivers, actually extending the doctor's reach and ability to help," said Christophe Sevrain, managing director, Delphi Medical Systems. "Imagine a patient with a chronic illness who now only has to make an arduous trip to the doctor once a month, unless their caregiver sees something that requires unscheduled attention."

"VitalPoint™ Home was designed for all patients, even those who are not technology savvy, by providing them an easy to use touch screen," said Sevrain. "It gives reminders to patients and gives them simple visual as well as verbal instructions while using the equipment."

Additionally, a patient's concerned family member, with the consent of that patient, can also sign up through Delphi Medical Systems to remotely check on their loved one's condition from any computer or PDA, via the Internet.

"Once again Delphi Medical Systems is answering needs in the medical community," said Sevrain. "Patients want flexibility, better quality of life, and time savings and doctors want to give the best care to all of their patients, and grow their practice without necessary growing their physical office. VitalPoint Home gives them the ability to 'see' more patients daily, and the assurance that if there is a problem, the doctor will be able to help thanks to the remote vital signs monitoring technology."

For more information about Delphi Medical Systems, visit www.delphimedical.com. For more information on Delphi and its subsidiaries, visit www.delphi.com/media.

FORWARD-LOOKING STATEMENT
This press release as well as other statements made by Delphi may contain forward-looking statements within the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 that reflect, when made, the Company's current views with respect to current events and financial performance. Such forward looking statements are and will be, as the case may be, subject to many risks, uncertainties and factors relating to the Company's operations and business environment which may cause the actual results of the Company to be materially different from any future results, express or implied, by such forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following: the ability of the Company to continue as a going concern; the ability of the Company to operate pursuant to the terms of the DIP facility; the Company's ability to obtain court approval with respect to motions in the chapter 11 proceeding prosecuted by it from time to time; the ability of the Company to develop, prosecute, confirm and consummate one or more plans of reorganization with respect to the chapter 11 cases; risks associated with third parties seeking and obtaining court approval to terminate or shorten the exclusivity period for the Company to propose and confirm one or more plans of reorganization, for the appointment of a chapter 11 trustee or to convert the cases to chapter 7 cases; the ability of the Company to obtain and maintain normal terms with vendors and service providers; the Company's ability to maintain contracts that are critical to its operations; the potential adverse impact of the chapter 11 cases on the Company's liquidity or results of operations; the ability of the Company to fund and execute its business plan; the ability of the Company to attract, motivate and/or retain key executives and associates; and the ability of the Company to attract and retain customers. Other risk factors are listed from time to time in the Company's SEC reports, including, but not limited to the annual report on Form 10-K for the year ended December 31, 2005 and its most recent quarterly report on Form 10-Q and current reports on Form 8-K Delphi disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Similarly, these and other factors, including the terms of any reorganization plan ultimately confirmed, can affect the value of the Company's various pre-petition liabilities, common stock and/or other equity securities. No assurance can be given as to what values, if any, will be ascribed in the bankruptcy proceedings to each of these constituencies. Accordingly, the Company urges that the appropriate caution be exercised with respect to existing and future investments in any of these liabilities and/or securities.

NOTE: This product is not an emergency response system. Patients whose symptoms need immediate response still immediately need to call 9-1-1 or their medical care provider.